CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Assets
Cash and due from banks	$ 4,884	$ 12,716
Interest bearing deposits with banks	167,565	167,660
Cash and cash equivalents	172,449	180,376
Investment securities available for sale, at fair value	6,041	7,095
Investment securities held to maturity, net of allowance for credit losses of $0 at September 30, 2024 and December 31, 2023 (fair value of $7,872 at September 30, 2024 and $7,892 at December 31, 2023)	9,228	9,292
Total investment securities	15,269	16,387
Loans, net of unearned income	1,839,929	1,787,340
Less: Allowance for credit losses	(32,318)	(32,131)
Net loans	1,807,611	1,755,209
Accrued interest receivable	9,242	8,555
Premises and equipment, net	5,365	5,579
Restricted stock	8,619	7,636
Bank owned life insurance (BOLI)	28,904	28,415
Deferred tax asset	9,214	9,262
Other real estate owned (OREO)	1,562	1,550
Other	7,174	10,531
Total assets	2,065,409	2,023,500
Deposits
Noninterest-bearing deposits	198,499	232,189
Interest-bearing deposits	1,360,384	1,320,638
Total deposits	1,558,883	1,552,827
FHLBNY borrowings	145,000	125,000
Subordinated debentures	43,253	43,111
Accrued interest payable	7,112	4,146
Other	14,701	14,099
Total liabilities	1,768,949	1,739,183
Shareholders' Equity
Preferred stock, 1,000,000 shares authorized, $1,000 liquidation value Series B non-cumulative convertible; 325 shares and 375 shares outstanding at September 30, 2024 and December 31, 2023, respectively	325	375
Common stock, $0.10 par value; authorized 15,000,000 shares; Issued: 12,264,116 shares and 12,240,821 shares at September 30, 2024 and December 31, 2023, respectively	1,226	1,224
Additional paid-in capital	137,130	136,700
Retained earnings	163,085	149,437
Accumulated other comprehensive loss	(267)	(404)
Treasury stock, 381,723 shares and 284,522 shares at September 30, 2024 and December 31, 2023, at cost	(5,039)	(3,015)
Total shareholders’ equity	296,460	284,317
Total liabilities and shareholders' equity	$ 2,065,409	$ 2,023,500